Edition:
United Kingdom

Cellular Biomedicine Group Inc (CBMG.OQ)

CBMG.OQ on NASDAQ Stock Exchange Global Market

20.98USD
20 Sep 2018
Change (% chg)

-- (--)
Prev Close
$20.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
18,137
52-wk High
$23.00
52-wk Low
$9.25

Chart for

About

Cellular Biomedicine Group Inc. is engaged in the development of cell therapy technologies. The Company develops cell therapies for the treatment of cancer and degenerative diseases. The Company conducts immuno-oncology and stem cell clinical trials in China using products from the goods manufacturing practices (GMP) laboratory.... (more)

Overall

Beta: 2.74
Market Cap(Mil.): $147.44
Shares Outstanding(Mil.): 14.11
Dividend: --
Yield (%): --

Financials

  CBMG.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -2.05 -- --
ROI: -41.46 1.78 14.61
ROE: -41.55 3.27 16.33

BRIEF-Cellular Biomedicine Group Qtrly Loss Per Share $0.51

* CELLULAR BIOMEDICINE GROUP REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND HIGHLIGHTS OPERATIONAL PROGRESS

08 May 2018

Earnings vs. Estimates